Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Beutels

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Vaccine|August 17, 2004
Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccinationPhilippe Beutels
Pharmacoeconomics|September 27, 2022
Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine"Joke Bilcke, Philippe Beutels
Pharmacoeconomics|July 10, 2009
Costing infectious disease outbreaks for economic evaluation: a review for hepatitis AJeroen Luyten, Philippe Beutels
Plos One|September 17, 2020
Recent quantitative research on determinants of health in high income countries: A scoping reviewVladimira Varbanova, Philippe Beutels
The Lancet Regional Health. Europe|June 26, 2021
Ceci n'est pas un lit. Base capacity healthcare matters in a pandemicPhilippe Beutels, Frederik Verelst
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 15, 2021
Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better PracticeJoke Bilcke, Philippe Beutels
Journal of Infection and Public Health|June 8, 2023
The estimated disease burden of COVID-19 in Japan from 2020 to 2021Shinya Tsuzuki, Philippe Beutels
Sexual Health|August 20, 2010
A brief history of economic evaluation for human papillomavirus vaccination policyPhilippe Beutels, Mark Jit
Health Affairs (Project Hope)|February 10, 2016
The Social Value Of Vaccination Programs: Beyond Cost-EffectivenessJeroen Luyten, Philippe Beutels
Health Affairs (Project Hope)|May 4, 2016
'Egocentric' Vaccination: The Authors ReplyJeroen Luyten, Philippe Beutels
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Vaccine|August 17, 2004
Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccinationPhilippe Beutels
Pharmacoeconomics|September 27, 2022
Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine"Joke Bilcke, Philippe Beutels
Pharmacoeconomics|July 10, 2009
Costing infectious disease outbreaks for economic evaluation: a review for hepatitis AJeroen Luyten, Philippe Beutels
Plos One|September 17, 2020
Recent quantitative research on determinants of health in high income countries: A scoping reviewVladimira Varbanova, Philippe Beutels
The Lancet Regional Health. Europe|June 26, 2021
Ceci n'est pas un lit. Base capacity healthcare matters in a pandemicPhilippe Beutels, Frederik Verelst
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 15, 2021
Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better PracticeJoke Bilcke, Philippe Beutels
Journal of Infection and Public Health|June 8, 2023
The estimated disease burden of COVID-19 in Japan from 2020 to 2021Shinya Tsuzuki, Philippe Beutels
Sexual Health|August 20, 2010
A brief history of economic evaluation for human papillomavirus vaccination policyPhilippe Beutels, Mark Jit
Health Affairs (Project Hope)|February 10, 2016
The Social Value Of Vaccination Programs: Beyond Cost-EffectivenessJeroen Luyten, Philippe Beutels
Health Affairs (Project Hope)|May 4, 2016
'Egocentric' Vaccination: The Authors ReplyJeroen Luyten, Philippe Beutels
Pageof 26